Related references
Note: Only part of the references are listed.Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma
Glynis A. Scott et al.
MODERN PATHOLOGY (2014)
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas
Klaus G. Griewank et al.
MODERN PATHOLOGY (2014)
TERT promoter mutations in primary and secondary glioblastomas
Naosuke Nonoguchi et al.
ACTA NEUROPATHOLOGICA (2013)
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
Marc Remke et al.
ACTA NEUROPATHOLOGICA (2013)
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
K. G. Griewank et al.
BRITISH JOURNAL OF CANCER (2013)
TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine
Isaac Kinde et al.
CANCER RESEARCH (2013)
The Role of Telomeres in Stem Cells and Cancer
Cagatay Guenes et al.
CELL (2013)
Conjunctival Melanomas Harbor BRAF and NRAS Mutations and Copy Number Changes Similar to Cutaneous and Mucosal Melanomas
Klaus G. Griewank et al.
CLINICAL CANCER RESEARCH (2013)
Lack of SF3B1 R625 mutations in cutaneous melanoma
Bastian Schilling et al.
DIAGNOSTIC PATHOLOGY (2013)
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Xiaoli Liu et al.
ENDOCRINE-RELATED CANCER (2013)
Genetic alterations in RAS-regulated pathway in acral lentiginous melanoma
Joan A. Puig-Butille et al.
EXPERIMENTAL DERMATOLOGY (2013)
Frequent Somatic TERT Promoter Mutations in Thyroid Cancer: Higher Prevalence in Advanced Forms of the Disease
Inigo Landa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
J. William Harbour et al.
NATURE GENETICS (2013)
TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism
P. Sivaramakrishna Rachakonda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Frequency of TERT promoter mutations in human cancers
Joao Vinagre et al.
NATURE COMMUNICATIONS (2013)
Current appraisal of conjunctival melanocytic tumors: classification and treatment
Hooman Harooni et al.
FUTURE ONCOLOGY (2011)
Conjunctival Melanoma Outcomes Based on Tumor Origin in 382 Consecutive Cases
Carol L. Shields et al.
OPHTHALMOLOGY (2011)
Mutations in GNA11 in Uveal Melanoma.
Catherine D. Van Raamsdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
Distinct sets of genetic alterations in melanoma
JA Curtin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS
W Zuidervaart et al.
BRITISH JOURNAL OF CANCER (2005)
Senescence and immortalization: role of telomeres and telomerase
JW Shay et al.
CARCINOGENESIS (2005)
Lack of BRAF mutation in primary uveal melanoma
Y Cohen et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Absence of mutations of the BRAF gene and constitutive activation of extracellular-regulated kinase in malignant melanomas of the uvea
A Weber et al.
LABORATORY INVESTIGATION (2003)
Share Paper
